Evidence map›Paper›PMID 34362780›Full record

GuidelineGut2021

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.

Andrew M Veitch, Franco Radaelli, Raza Alikhan, Jean Marc Dumonceau, Diane Eaton, Jo Jerrome, Will Lester, David Nylander, Mo Thoufeeq, Geoffroy Vanbiervliet and 2 more

2 registry-linked trialsOpen access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 90 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 3 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06393907 naunknown statusnot on this mapstarted 2024, after this paper: background citation

A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

TypeinterventionalSponsorMahidol UniversityRan2024 to 2026Enrolled150ConditionsGastroduodenal UlcerArmsHemostatic Forceps, Bipolar Electrocautery Probes
NCT07052799 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy; a Placebo-controlled Trial

TypeinterventionalSponsorChinese University of Hong KongRan2026 to 2031Enrolled2,514ConditionsMyocardial Infarction (MI), Cardiovascular Events, Post Polypectomy Bleeding in Antiplatelet PatientsArmsAspirin 80mg, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 3 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Clinical Practice Guidelines for Peroral Cholangioscopy.Journal of hepato-biliary-pancreatic sciences · 2026
    Guideline
  2. Guideline
  3. Guideline
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Management of Peptic Ulcer Disease in Patients Taking Antithrombotic Agents.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Cystic neoplasms of pancreas.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Andrew M VeitchGastroenterology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK Andrew.veitch@nhs.net.ORCID 0000-0001-5418-2370
Franco RadaelliGastroenterology Unit, Valduce Hospital, Como, Italy.ORCID 0000-0003-3705-841X
Raza AlikhanHaematology, Cardiff and Vale University Health Board, Cardiff, UK.
Jean Marc DumonceauGastroenterology, Charleroi University Hospitals, Charleroi, Belgium.
Diane EatonAnticoagulation UK, London, UK.
Jo JerromeThrombosis UK, Llanwrda, UK.
Will LesterDepartment of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
David NylanderGastroenterology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Mo ThoufeeqGastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Geoffroy VanbiervlietPole Digestif, Hôpital Universitaire L'Archet 2, Nice, France.
James R WilkinsonInterventional Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Jeanin E Van HooftGastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
University Gastroenterology · USCardiff and Vale University Health Board · GBHôpital l'Archet · FRLeiden University Medical Center · NLNewcastle upon Tyne Hospitals NHS Foundation Trust · GBQueen Elizabeth Hospital Birmingham · GBSheffield Teaching Hospitals NHS Foundation Trust · GBThrombosis Research Institute · GBUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant therapy. The guideline development committee included representatives from the British Society of Haematology, the British Cardiovascular Intervention Society, and two patient representatives from the charities Anticoagulation UK and Thrombosis UK, as well as gastroenterologists. The process conformed to AGREE II principles and the quality of evidence and strength of recommendations were derived using GRADE methodology. Prior to submission for publication, consultation was made with all member societies of ESGE, including BSG. Evidence-based revisions have been made to the risk categories for endoscopic procedures, and to the categories for risks of thrombosis. In particular a more detailed risk analysis for atrial fibrillation has been employed, and the recommendations for direct oral anticoagulants have been strengthened in light of trial data published since the previous version. A section has been added on the management of patients presenting with acute GI haemorrhage. Important patient considerations are highlighted. Recommendations are based on the risk balance between thrombosis and haemorrhage in given situations.

Indexed as

AnticoagulantsAtrial FibrillationCholangiopancreatography, Endoscopic RetrogradeEndoscopyGastrointestinal HemorrhageGastroscopyHumansPlatelet Aggregation InhibitorsRisk FactorsThrombosisAnticoagulantsPlatelet Aggregation Inhibitorsendoscopic procedures

Identifiers

PMID34362780
PMCPMC8355884
OpenAlexW3187375489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.